Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Strengthening the University of Plovdiv Research Potential in Plant Systems Biology and Food Biotechnology (BIOSUPPORT)

Framework: FP7 — Capacities
Programme: Research Potential
Destination: Unlocking and developing the Research Potential of research entities established in the EU�s Convergence regions and Outermost Regions
Action type: Coordination and support actions
Countries involved: Bulgaria
Call:  (FP7-REGPOT-2009-1, 2009)
Start date: 2009-12-01
End date: 2013-05-31
Duration (months): 42.0
Total project cost (EUR): 2477040.0
EU funding (EUR): 2210514.0
Participants: 1
Project status: CLOSED

Currently, the University of Plovdiv (UoP) and the Faculty of Biology (FoB) is covering a wide field of research activities which can be put under the area of plant systems biology, food testing and biotechnology. It is one of the best performing research organizations in Bulgaria in its field. It hosts very well trained core staff, with researchers that have been serving different trainings and work periods in high level European universities and have good quality publications in peer review international journals. Nevertheless UoP-FoB urgently needs to keep-up with the contemporary science in the field and to strengthen its human resources capacity and research infrastructure. The main opportunities would be more and better trained staff, better connections and dissemination of results, leading to the upgrading to a larger, better organized and much stronger research infrastructure with significant regional impact on the industry and strong partnership with leading EU research institutions. The objective of this project would be also to further consolidate the full research capacities of the UoP-FoB with the support from affiliated scientists from two other Faculties by supporting its action plan for future development in one general field which has been under development for the last 15 years by different research groups. Strong cooperation with regional SMEs and food industry as a whole would be another important objective, achieved both by inclusion of SMEs in the project team and external support from the major industry players in the country in the field of Plant and Food Biotechnology. This will be achieved by acquiring of new equipment, series of mobility of the scientists in different high quality European research institutions, secondment periods of prominent European researchers in UoP, organizing conference and workshops in key topics for the UoP, and visiting international scientific events.

Keywords: systems biology,genomics,bioinformatics,food testing,food safety
Fernand Braudel International Fellowships for Experienced Researchers in Social Sciences and Humanities (BRAUDEL-IFER-FMSH)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Co-funding of regional, national and international programmes
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: France
Call:  (FP7-PEOPLE-COFUND-2008, 2008)
Start date: 2011-02-01
End date: 2016-01-31
Duration (months): 60.0
Total project cost (EUR): 5488086.0
EU funding (EUR): 2195234.4
Participants: 1
Project status: CLOSED

The Foundation Maison des Sciences de l’Homme (FMSH, Paris), created by Fernand Braudel, presents a project for co-funding of its international fellowship programmes for experienced researchers. In France, FMSH is one of the most important actors in postdoctoral international mobility for researchers in social sciences and humanities.Equipped with a large research library and hosting research programmes and centres mainly tied to CNRS, EHESS, Paris universities and the Fondation Nationale de Science Politique, FMSH is the largest establishment in the country for hosting and providing work facilities for researchers in social sciences and humanities from all over the world. At the postdoctoral level, FMSH has, for more than twenty years, managed international fellowship programmes for incoming researchers, along with an outgoing programme for researchers from French research institutions. These fellowship programmes are currently co-financed by CNRS, French ministries as well as by German and American private foundations. In the framework of these programmes, some 50 foreign postdoctoral fellows arrive each year to work in French research labs for 3 to 12 months, and 6 to 8 French fellows are sent for research in Germany, for 3 to 10 months. Annual volume is about 320 fellow-months. In addition, a large number of senior researchers are hosted (totalling more than 80 fellow-months), along with postdoctoral fellows with third-party financing (40 to 50 fellow-months). 33 countries are currently eligible for incoming fellowships, while only one is eligible for outgoing French fellows. The COFUND proposal&apos;s objectives are to: 1) broaden the list of eligible countries, especially for European countries; 2) increase the average stay from 6 to 9 months and create possibilities for foreign fellows to benefit from additional stays needed to complete their research project in institutes in France and other EU countries; 3) increase the number of fellows.

Keywords: humanities,social sciences,international post-doctoral mobility (experienced researchers),ingoing/outgoing,extra-european countries
Translating basic research findings in major human diseases (TRANSMED)

Framework: FP7 — Capacities
Programme: Research Potential
Destination: Unlocking and developing the Research Potential of research entities established in the EU�s Convergence regions and Outermost Regions
Action type: Coordination and support actions
Countries involved: Greece
Call:  (FP7-REGPOT-2009-1, 2009)
Start date: 2010-01-01
End date: 2013-06-30
Duration (months): 42.0
Total project cost (EUR): 1664960.0
EU funding (EUR): 1479316.0
Participants: 1
Project status: CLOSED

Improvement of human health requires translation of the basic research discoveries into practical applications for human disease, including biomarker identification, novel clinical tools, and medications. The scope of TranSMed is to support the development of a center of excellence in the EU target area of “translational research for major human diseases”, in the convergence region of Attica, Greece. The applicants will combine their expertise for the development of a facility for improvement of human health in the mission areas of obesity, metabolic syndrome and neurodegeneration. The principal aim of the group is to maintain and advance academic excellence, to enhance innovative research , and ultimately advance diagnosis and management of the above diseases. Participants have made substantial scientific contributions, and now are poised as a group to get to the next level and make a major impact on translational research. This will be achieved by unlocking their potential via the actions supported by REGPOT1, such as (i) upgrading the research capability by hiring experienced scientists and expansion of the equipment infrastructure (ii) integration in the ERA via strategic partnerships, including twinning, for transfer of knowledge from excellent EU centers, (iii) development of new lines of research including bidirectional communication with clinicians, and training in interdisciplinary approaches (iv) development of a platform for data mining and bioinformatics approaches. The above will be supported by networking activities, such as international workshops, to promote research collaborations with industrial partners. The latter will increase the visibility of the group and of the regional community. Ultimately, TranSMed can provide the basis for related projects to be supported through the cohesion policy program, resulting in dissemination of similar actions at national level and in the wider EU area including the new member countries in the Balkan vicinity.

Keywords: translational research,preclinical,parkinson's disease,obesity,metabolic syndrome,proteomics,twinning,repatriation,bioinformatics,imaging
SILICON NANODOTS FOR SOLAR CELL TANDEM (NASCENT)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Nanosciences and Nanotechnologies
Action type: Collaborative project
Countries involved: Germany,Germany,Italy,Spain,Czechia,Germany
Call:  (FP7-NMP-2009-SMALL-3, 2009)
Start date: 2010-09-01
End date: 2013-08-31
Duration (months): 36.0
Total project cost (EUR): 4119514.8
EU funding (EUR): 2982855.0
Participants: 8
Project status: CLOSED

The overall objective of the project is to develop new Nanomaterials with New Production Technologies and to fabricate silicon quantum dot tandem solar cells to achieve increased efficiencies. The understanding of electrical transport and recombination mechanisms in these newly developed nanomaterials will enable us to design new tandem solar cell structures - based on Si thin-film or wafer solar cells - that help to overcome the efficiency limits of these conventional concepts. In order to reach our goals, considerable R+D work has to be performed on semiconductor bulk materials, thin layers and hetero-structures for such solar cells. These topics have not yet or only in parts been investigated and are also of high scientific interest for novel photonic and charge storage devices incorporating Si nanocrystals embedded in Si alloys. The consortium of this project, also including two companies, merges the scientific and technological competences that are necessary to find answers to these questions. Another objective is the compatibility of the newly developed technologies with high-throughput processing to ensure further cost-reduction. The expected significant jump in the solar cell and processing evolution will lead to higher efficiencies for solar cells and to ongoing cost-reduction also with a long-term perspective and will help to strengthening the European leadership in PV technologies. Thus it will also have a positive impact on the acceptance of photovoltaics by the public and by politics. Moreover, since “energy efficiency” is a big subject in the public discussion, photovoltaics will be an example of one of the highest electricity production efficiencies that have been achieved of all power generators. To sum up, we believe that this project will have a direct and positive impact on the European PV industry and its status in material science and it will contribute to the very ambitious goals of the EU commission in CO2 reduction in general.

Keywords: quantum dot,tandem solar cell,nanoscience
Gene Activated Matrices for Bone and Cartilage Regeneration in Arthritis (GAMBA)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Materials
Action type: Collaborative project
Countries involved: Germany,Switzerland,Ireland,France,France,Netherlands,Italy,France,Germany
Call:  (FP7-NMP-2009-SMALL-3, 2009)
Start date: 2010-09-01
End date: 2013-08-31
Duration (months): 36.0
Total project cost (EUR): 4080393.6
EU funding (EUR): 3198849.0
Participants: 9
Project status: CLOSED

This consortium develops a novel gene-activated matrix platform for bone and cartilage repair with a focus on osteoarthritis-related tissue damage. The S&amp;T objectives of this project are complemented with an innovative program of public outreach, actively linking patients and society to the evolvement of this project. The GAMBA platform is going to implement a concept of spatiotemporal control of regenerative bioactivity on command and demand. A gene-activated matrix is a biomaterial with embedded gene vectors that will genetically modify cells embedded in the matrix. The platform comprises modules that self-adapt to the biological environment and that can be independently addressed with endogenous biological and exogenous physical or pharmacological stimuli, resulting in a temporally and spatially coordinated growth factor gene expression pattern. This reproduces, within the matrix, key elements of natural tissue formation. The modules are a biomimetic hyaluronan gel, a ceramic matrix, growth factor-encoding gene vector nanoparticles, magnetic nanoparticles and mesenchymal stem cells. Anatomical adaptivity is achieved with engineered thermal properties of the polymer matrix, which embeds other modules, selected according to functional requirements. Mechanical support is provided by Micro Macroporous Biphasic Calcium Phosphate (MBCP™), a resorbable material approved for clinical use. Spatiotemporal control of bioactivity and responsiveness to physiological conditions is represented, firstly, in the spatial distribution and release profiles of gene vectors within the composite matrix and, secondly, by letting local and external biological or physical stimuli activate the promoters driving the expression of vector-encoded transgenes. This innovative concept is implemented by a multidisciplinary team from leading European institutions combining scientific excellence with a focused plan of dissemination, public participation, gender equality and transition to market.

Keywords: gene-activated matrix tissue engineering gene therapy osteoarthritis thermo-responsive polymer stem cells magnetic nanoparticles
Capture of evaporated water with novel membranes (CAPWA)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Materials
Action type: Collaborative project
Countries involved: Netherlands,Israel,Spain,Italy,Netherlands,Tunisia,Ghana,Germany,Germany,Germany,Netherlands,South Africa,Germany
Call:  (FP7-NMP-2009-SMALL-3, 2009)
Start date: 2010-09-01
End date: 2013-08-31
Duration (months): 36.0
Total project cost (EUR): 5768329.8
EU funding (EUR): 3588140.0
Participants: 15
Project status: CLOSED

One of the major challenges of this century is the provision of safe drinking water for a growing population. The shortage in water resources in arid areas requires the availability of more efficient and cheaper drinking water production processes. For groundwater, it is often sufficient to aerate and disinfect to produce drinking water. However, in large parts of the world the use of groundwater from aquifers is not possible due to excessive use and global climate change that allow penetration of salt sea water into the aquifers. Population growth, not surprisingly, leads to more pollution of aquifers rendering the water quality unsuitable for drinking water purposes without excessive treatment. In contrast, there are always large quantities of water vapor present in air. The objective within CapWa is produce a commercially available membrane modular system suitable for industrial applications within 3-4 years. The produced demin water from this system should be competitive with existing demin water technologies. The starting point will be the water vapour selective composite membranes that are developed in the proof of principle project. At the same time fundamental research will also be done on other alternative water selecting coatings. For both of these membrane paths the upscale from lab to industrial scale membrane production will be developed in CapWa. In CapWa the modular membrane system will also be developed and tested in the flue gas duct of a gas and coal-fired power plant, a cooling tower (or geothermal well) and in a paper or board mill. To achieve this goal the selective membranes must be thermal/chemically stable under the existing environmental conditions (50-150 °C) and resistant to fouling. To be competitive with existing demin production lines, the construction of the end system must be efficient and user friendly.

Keywords: evaporated water capture membranes gas seperating
Modern polymer-based catalysts and microflow conditions as key elements of innovations in fine chemical syntheses (POLYCAT)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: New production
Action type: Collaborative project
Countries involved: Germany,France,Germany,Russian Federation,Finland,Germany,United Kingdom,France,Greece,Switzerland,Italy,Germany,Netherlands,Germany,Germany,Hungary
Call:  (FP7-NMP-2009-LARGE-3, 2009)
Start date: 2010-10-01
End date: 2014-03-31
Duration (months): 42.0
Total project cost (EUR): 10032377.88
EU funding (EUR): 6998220.0
Participants: 22
Project status: CLOSED

POLYCAT provides an integrated, coherent and holistic approach utilizing novel polymer based nanoparticulate catalysts in pharmaceutical, crop protection and vitamin syntheses in conjunction with the enabling functions of micro process technology and “green” solvents such as water or ethyl lactate. This provides a discipline bridging approach between fine chemistry, catalysis and engineering. This will lead to the replacement of a number of chemical or microbiological reaction steps in fine chemical syntheses by catalytic ones using more active, selective and stable nanoparticulate catalysts. In addition, POLYCAT will lead to the development of novel chiral modifiers immobilized on the polymeric supports. Micro process technology provides testing under almost ideal processing conditions, with much improved heat management, with improved costing, at high data validity, at high process confidence, and with high certainty for scale-out. The industrial applicability is demonstrated by scale-out of the industrial demonstration reactions to the pilot scale. A multi-purpose, container-type plant infrastructure will integrate individual reaction and separation modules in block format, standardised basic logistics, process control, safety installations, and on-line analytics. As guidance before (ex-ante) and during the whole development, holistic life cycle (LCA) and cost analyses will pave directions towards competitiveness and sustainability. The POLYCAT technologies have potential to reduce the environmental impact by 20% up to orders of magnitude: e.g. reduction of green house gas emissions, acids (SO2-Eq.), nutrients (NOx-Eq.), toxic substances (1,4-DCB Eq.) and finite abiotic resources (antimony eq.). With (enantio)selectivity increases up to 25%, solvent reductions of 30-100%, and products cost decreases of about 10%, a midterm impact of 30-110 Mio Euro and longterm impact of 100-560 Mio Euro result.

Keywords: polymer based nanoparticulate catalysts,vitamin and pharmaceutical syntheses,micro process technology,green solvents,multi-step container-type pilot plant,holistic life cycle analysis
InteGration of pRocess and quAlity Control using multi-agEnt technology (GRACE)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: New production
Action type: Collaborative project
Countries involved: Italy,Norway,Portugal,Italy,Germany
Call:  (FP7-NMP-2009-SMALL-3, 2009)
Start date: 2010-07-01
End date: 2013-06-30
Duration (months): 36.0
Total project cost (EUR): 4058406.2
EU funding (EUR): 2599999.0
Participants: 6
Project status: CLOSED

The GRACE main objective is to realize a cooperative multi agent system (MAS) operating at all stages of a manufacturing system, integrating process control with quality control, for developing: - self-adaptive procedures into control and diagnostic systems at local and global level handling variation in process set-point and variables and unplanned fluctuations of process/product parameters; - supervision and control schemes at factory level based on a continuous flow of information between agents; - factory-level decision making strategies based on data analysis methods; - a modular engineering methodology enabling the efficient use of MAS production platforms. The project seeks to close the gap between theory on MAS and adaptive/intelligent agents and the control systems actually implemented in manufacturing lines. To reach the goal of a real world validation of the results, the project considers the production of washing machines and will show: - improvement of production efficiency; - reduction of production-line down-time; - reduction of non-conformities by improved quality control of products. Five main scientific/technical objectives are foreseen: - Development of a flexible, adaptive and reconfigurable architecture integrating process and quality control - Development of self-adaptation and self-optimization mechanisms - Development of modular and adaptive testing systems - Enable systematic transferability and industrial applicability of GRACE - Prototype of the concept and real test case This project impacts on production engineering research through the development of technologies for flexible and re-configurable production, implementing the concept of adaptivity, for improving process capability, production efficiency and product quality, to build technological competitive advantage for leading manufacturing sectors in Europe. GRACE has a strong industrial involvement and a strong potential for industrial take-up and exploitation.

Keywords: multi-agent system,adaptive process,quality control,distributed manufacturing control
Adaptive Business Collaboration by progressive knowledge sharing and engineering (TRANSPARENCY)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: New production
Action type: Collaborative project
Countries involved: Germany,United Kingdom,Germany,Germany,Italy,France,Spain,Italy,Hungary,Germany,Germany
Call:  (FP7-NMP-2009-SME-3, 2009)
Start date: 2010-10-01
End date: 2013-09-30
Duration (months): 36.0
Total project cost (EUR): 4037398.55
EU funding (EUR): 2997865.0
Participants: 13
Project status: CLOSED

The vision of TRANSPARENCY is to allow European machine-tool builders for transferring their business into a machine-related cooperation of service oriented partners in a dynamic network. The project aims for a vertical integration of management, design and operation of machine-tools to provide long-ranging transparency for both the end users and the machine-tool builder throughout the whole life-time of the machine-tool. This is achieved by a knowledge based Collaborative Co-Design Environment approach using semantic technologies. Special attention will be paid for the conceptual system design stage, the feed-back of knowledge from the operational life-cycle stages. Life-cycle performance, knowledge about produced products, and experiences of human personnel will be constantly incorporated into the set of knowledge. Handling of complexity will be achieved by self-descriptive Active components and the realization of a flexible, knowledge based Co-Design Methodology. Advanced assessment and prediction tools with links to commercial of the shelf simulations will assess important key performance indicators to execute virtual test cases to support especially early design decisions. This will drastically reduce costly re-design cycles in detailed design. Furthermore, the continuous availability of dynamically assessed Life-Cycle Costing data will allow for constant total life cycle cost optimization of the machine-tool and its components. Via web-based collaboration and secure storage of data, the project will ensure that every responsible stakeholder will have access to all information available throughout the whole life-time of the product and towards the re-use or disposal of the machine-tool or its components.

Keywords: product life-cycle management (plm),machine-tool conceptual co-design,co-design methodology,life-cycle costing,knowledge management,semantic technologies,overall equipment effectiveness (oee)